Literature DB >> 8206622

Increased expression of growth hormone receptor mRNA and insulin-like growth factor-I mRNA in volume-overloaded hearts.

J Isgaard1, H Wåhlander, M A Adams, P Friberg.   

Abstract

Recent results suggest that insulin-like growth factor-I (IGF-I) may be involved in the transition of a hemodynamic load into cardiac hypertrophy and that the expression of IGF-I seems to be coupled to increased wall stress. The present study investigated the role of growth hormone (GH) and IGF-I in myocardial hypertrophy induced by volume overload. An aortocaval fistula (ACF) was created in male Wistar rats, and experiments were performed 2, 4, and 7 days after the onset of volume overload. Right and left ventricular (RV and LV, respectively) myocardial expression of GH receptor mRNA and IGF-I mRNA were quantitated by a solution hybridization RNase protection assay. RV GH receptor mRNA content was elevated on the fourth and seventh days after the induction of the shunt, with peak levels (0.63 +/- 0.16 versus 0.14 +/- 0.03 amol/microgram DNA for the sham-operated animals; P < .01) after 4 days. Similarly, IGF-I mRNA was significantly increased in the RV of shunted animals (1.26 +/- 0.13 versus 0.56 +/- 0.05 amol/micrograms DNA; P < .01) 7 days after surgery. In the left ventricle, where systolic pressure was reduced in ACF rats, no differences could be detected in GH receptor and IGF-I mRNA content between ACF and sham-operated rats on any of the experimental days. There was no difference in the ratio of RV to LV weight during the experimental period. We have shown that the thin-walled right ventricle responds to volume overload with an increase of GH receptor mRNA content followed by elevated expression of IGF-I mRNA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206622     DOI: 10.1161/01.hyp.23.6.884

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

2.  Human heart shifts from IGF-1 production to utilization with chronic heart failure.

Authors:  Roberta D'Assante; Raffaele Napoli; Andrea Salzano; Carlotta Pozza; Alberto Maria Marra; Michele Arcopinto; Giuseppe Perruolo; Salvatore Milano; Pietro Formisano; Lavinia Saldamarco; Plinio Cirillo; Antonio Cittadini
Journal:  Endocrine       Date:  2019-07-02       Impact factor: 3.633

Review 3.  Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Authors:  John J Kopchick; Reetobrata Basu; Darlene E Berryman; Jens O L Jorgensen; Gudmundur Johannsson; Vishwajeet Puri
Journal:  Nat Rev Endocrinol       Date:  2022-06-24       Impact factor: 47.564

4.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

5.  Basal and IGF-I-dependent regulation of potassium channels by MAP kinases and PI3-kinase during eccentric cardiac hypertrophy.

Authors:  Leyla Y Teos; Aiqiu Zhao; Zikiar Alvin; Graham G Laurence; Chuanfu Li; Georges E Haddad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-29       Impact factor: 4.733

6.  Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).

Authors:  A I Pincelli; R Bragato; M Scacchi; G Branzi; G Osculati; R Viarengo; G Leonetti; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

7.  Effects of IGF-1 on I(K) and I(K1) Channels via PI3K/Akt Signaling in Neonatal Cardiac Myocytes.

Authors:  Richard M Millis; Zikiar V Alvin; Aiqiu Zhao; Georges E Haddad
Journal:  Int J Cell Biol       Date:  2012-06-18

Review 8.  Cardiovascular effects of growth hormone.

Authors:  W J Brickman; B L Silverman
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

Review 9.  Hormone treatments in congestive heart failure.

Authors:  Lei Lei; Yuanjie Mao
Journal:  J Int Med Res       Date:  2018-02-22       Impact factor: 1.671

Review 10.  GH and the cardiovascular system: an update on a topic at heart.

Authors:  Jörgen Isgaard; Michele Arcopinto; Kristjan Karason; Antonio Cittadini
Journal:  Endocrine       Date:  2014-06-28       Impact factor: 3.633

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.